Mainz Biomed N.V.
MYNZ
$4.37
-$0.365-7.72%
| 12/31/2023 | 06/30/2023 | 12/31/2022 | 09/30/2021 | 03/31/2021 | |
|---|---|---|---|---|---|
| Revenue | 214.80K | 248.90K | 193.30K | 80.00K | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 214.80K | 248.90K | 193.30K | 80.00K | -- |
| Cost of Revenue | 80.00K | 100.10K | 157.00K | 167.50K | -- |
| Gross Profit | 134.70K | 148.80K | 36.30K | -87.50K | -- |
| SG&A Expenses | 4.73M | 4.96M | 5.11M | 4.52M | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.81M | 8.18M | 8.58M | 4.82M | -- |
| Operating Income | -6.59M | -7.93M | -8.39M | -4.74M | -- |
| Income Before Tax | -5.18M | -8.25M | -8.19M | -5.71M | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.18M | -8.25M | -8.19M | -5.71M | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.18M | -8.25M | -8.19M | -5.71M | -- |
| EBIT | -6.59M | -7.93M | -8.39M | -4.74M | -- |
| EBITDA | -6.32M | -7.88M | -8.36M | -4.73M | -- |
| EPS Basic | -10.86 | -22.13 | -21.60 | -0.65 | -- |
| Normalized Basic EPS | -7.72 | -- | -13.50 | -0.33 | -- |
| EPS Diluted | -10.86 | -22.13 | -21.60 | -0.65 | -- |
| Normalized Diluted EPS | -7.72 | -- | -13.50 | -0.33 | -- |
| Average Basic Shares Outstanding | 477.20K | 372.90K | 379.10K | 8.81M | -- |
| Average Diluted Shares Outstanding | 477.20K | 372.90K | 379.10K | 8.81M | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
